|
Market Closed -
NSE India S.E.
19:05:10 28/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1,757.50 INR | +0.36% |
|
+0.71% | +2.20% |
| Market Cap | 4,217B 44.28B 39.72B 36.73B 33.26B 62.14B 62.89B 439B 175B 2,207B 166B 163B 7,005B | P/E 2027 * |
32.8x | P/E 2028 * | 27.4x |
|---|---|---|---|---|---|
| Enterprise Value | 3,925B 41.21B 36.97B 34.18B 30.96B 57.84B 58.54B 409B 163B 2,054B 155B 151B 6,520B | EV / Sales 2027 * |
6.03x | EV / Sales 2028 * | 5.3x |
| Free-Float |
44.39% | Yield 2027 * |
0.97% | Yield 2028 * | 1.13% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| SUNPHARMA | Delayed | |
Bombay S.E.
| 524715 | Delayed |
Last Transcript: Sun Pharmaceutical Industries Ltd.
| 1 day | +0.36% | ||
| 1 week | +0.71% | ||
| Current month | -3.25% | ||
| 1 month | -4.38% | ||
| 3 months | -11.09% | ||
| 6 months | +0.58% | ||
| Current year | +2.20% |
| 1 week | 1,726.2 |  | 1,767.9 |
| 1 month | 1,719.1 | | 1,863.6 |
| Current year | 1,583.7 | | 2,046.9 |
| 1 year | 1,583.7 | | 2,046.9 |
| 3 years | 1,068.35 | | 2,046.9 |
| 5 years | 733.7 | | 2,046.9 |
| 10 years | 312 | | 2,046.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Chief Executive Officer | 59 | 01/09/2025 | |
| Director of Finance/CFO | 58 | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
| Director/Board Member | 59 | 01/09/2025 | |
| Director/Board Member | 71 | 21/05/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.36% | +0.71% | +4.18% | +58.15% | 44.24B | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,143B | |
| +0.86% | +5.14% | +45.00% | +86.15% | 647B | |
| -0.14% | +0.42% | +25.69% | +105.85% | 506B | |
| -0.05% | +1.73% | +52.74% | +67.74% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.06% | 350B | |
| +0.34% | +1.84% | +30.70% | +54.27% | 293B | |
| -0.45% | +1.19% | +2.89% | +26.08% | 265B | |
| +0.87% | +3.08% | +54.69% | +72.74% | 242B | |
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | |
| Average | +0.17% | +1.35% | +36.99% | +74.58% | 407.18B | |
| Weighted average by Cap. | +0.26% | +1.54% | +44.06% | +88.68% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 651B 6.84B 6.13B 5.67B 5.14B 9.59B 9.71B 67.79B 27B 341B 25.65B 25.11B 1,081B | 730B 7.66B 6.87B 6.35B 5.75B 10.75B 10.88B 75.97B 30.26B 382B 28.75B 28.14B 1,212B |
| Net income | 130B 1.36B 1.22B 1.13B 1.02B 1.91B 1.93B 13.49B 5.37B 67.78B 5.1B 5B 215B | 155B 1.63B 1.46B 1.35B 1.22B 2.29B 2.31B 16.15B 6.43B 81.17B 6.11B 5.98B 258B |
| Net Debt | -292B -3.07B -2.75B -2.54B -2.3B -4.3B -4.35B -30.4B -12.11B -153B -11.5B -11.26B -485B | -353B -3.7B -3.32B -3.07B -2.78B -5.2B -5.26B -36.72B -14.63B -185B -13.89B -13.6B -586B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | ₹1,757.50 | +0.36% | 1,056,767 |
| 27/10/26 | ₹1,751.20 | +0.64% | 1,547,898 |
| 26/10/26 | ₹1,740.00 | -0.46% | 1,622,698 |
| 23/10/26 | ₹1,748.00 | -0.57% | 1,064,528 |
| 22/10/26 | ₹1,758.00 | +0.74% | 1,778,519 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUNPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
